Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Peringkat dalam Saham #38880
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Harga Saham
$0.07475
Terakhir disinkronkan: 2024-03-04
Kapitalisasi Pasar
$755.60K
Perubahan (1 hari)
-6.68%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Bellicum Pharmaceuticals, Inc. (BLCM)

Kategori

Healthcare
Riwayat harga saham Bellicum Pharmaceuticals, Inc. (BLCM)
Harga penutupan tertinggi: $0.08 pada 2024-03-01

Harga penutupan terendah: $214.46 pada 2014-12-01
Riwayat harga saham Bellicum Pharmaceuticals, Inc. dari 2014 hingga 2026
Performa harga saham tahunan
Tahun Performa
2024 -58.98%
2023 -77.47%
2022 -48.69%
2021 -48.79%
2020 -67.81%
2019 -72.37%
2018 -59.58%
2017 -43.00%
2016 -22.19%
2015 -6.78%
2014 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.92 29.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.33 29.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE